218 results on '"Hesterman, Jacob"'
Search Results
2. Application of Aligned-UMAP to longitudinal biomedical studies
3. Neurophysiological Biomarkers of Parkinson’s Disease
4. The VIDA software for targeted radionuclide therapy
5. Noninvasive PK11195‐PET Image Analysis Techniques Can Detect Abnormal Cerebral Microglial Activation in Parkinson's Disease
6. Deep Volumetric Feature Encoding for Biomedical Images
7. High-Level Story: Data Analysis in Multimodal Preclinical Imaging—Methods and Tools
8. How Can Radiopharmaceutical Therapies Reach Their Full Potential? Improving Dose Reporting and Phase I Clinical Trial Design.
9. Deep Volumetric Feature Encoding for Biomedical Images
10. Automated segmentation of MR imaging to determine normative central nervous system cerebrospinal fluid volumes in healthy volunteers
11. Convective forces increase rostral delivery of intrathecal radiotracers and antisense oligonucleotides in the cynomolgus monkey nervous system
12. High-Level Story: Data Analysis in Multimodal Preclinical Imaging—Methods and Tools
13. High-throughput high-volume nuclear imaging for preclinical in vivo compound screening§
14. Concurrent 3D super resolution on intensity and segmentation maps improves detection of structural effects in neurodegenerative disease
15. A gradient-loadable 64Cu-chelator for quantifying tumor deposition kinetics of nanoliposomal therapeutics by positron emission tomography
16. Application of Aligned-UMAP to longitudinal biomedical studies
17. Advancing Drug Discovery and Development Using Molecular Imaging (ADDMI): an Interest Group of the World Molecular Imaging Society and an Inaugural Session on Positron Emission Tomography (PET)
18. [68Ga]Ga-PSMA-11 PET baseline imaging as a prognostic tool for clinical outcomes to [177Lu]Lu-PSMA-617 in patients with mCRPC: A VISION substudy.
19. Baseline amyloid and tau PET imaging characteristics in the ongoing phase 2 study of tilavonemab in early Alzheimer’s disease
20. Micro-CT imaging: Developing criteria for examining fetal skeletons in regulatory developmental toxicology studies – A workshop report
21. Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency
22. Radiation dosimetry in translational intrathecal imaging
23. Practical applications of machine learning in imaging trials
24. Adaptive SPECT
25. Deep volumetric super‐resolution improves the detection of amyloid‐related cross‐sectional group differences in MCI
26. Amyloid IQ : An advanced analytical algorithm to quantify amyloid‐PET [ 18 F]NAV4694 scans
27. Intersectional innovation in biomarker development for patient-centric medicine
28. Abstract 3192: Quanticell, a novel histopathology technology for visualization and quantitation of membrane PSMA demonstrated in cell lines and clinical tissue
29. Convective forces increase rostral delivery of intrathecal antisense oligonucleotides in the cynomolgus monkey nervous system
30. Intrathecal 99m Tc‐DTPA imaging of molecular passage from lumbar cerebrospinal fluid to brain and periphery in humans
31. Pre-Clinical Evaluation of 225Ac-DOTATOC Pharmacokinetics, Dosimetry, and istopathology to Enable Phase-1 Clinical Trial in Patients with Neuroendocrine Tumors
32. Quantitative 68Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following 177Lu-PSMA-617 (VISION Trial)
33. Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging
34. O4-02-01: PHASE 2A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE HISTONE DEACETYLASE INHIBITOR (HDACI), FRM-0334, IN ASYMPTOMATIC CARRIERS OF, OR PATIENTS WITH FRONTOTEMPORAL LOBAR DEGENERATION (FTLD) DUE TO, PROGRANULIN GENE MUTATIONS
35. P3-026: IMPLEMENTATION OF DUAL-PHASE FLORBETAPIR PET IN THE MULTICENTER PHASE 2 NAVIGATE-AD CLINICAL TRIAL
36. IC-P-151: TAUIQ : A QUANTITATIVE ALGORITHM TO INCREASE THE POWER OF TAU PET IMAGING IN CLINICAL TRIALS
37. P4-298: TAUIQ - A QUANTITATIVE ALGORITHM TO INCREASE THE POWER OF TAU PET IMAGING IN CLINICAL TRIALS
38. Pre-Clinical Evaluation of 225Ac-DOTATOC Pharmacokinetics, Dosimetry, and Histopathology to Enable Phase-1 Clinical Trial in Patients with Neuroendocrine Tumors
39. Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double‐blind, placebo‐controlled cross‐over trial
40. A phase one, single-dose, open-label, clinical safety and PET/MR imaging study of 68Ga-DOTATOC in healthy volunteers
41. Additional file 1: of High-throughput high-volume nuclear imaging for preclinical in vivo compound screening§
42. 111In-DANBIRT In Vivo Molecular Imaging of Inflammatory Cells in Atherosclerosis
43. P1‐037: BASELINE CHARACTERISTICS FOR PATIENTS WITH MILD ALZHEIMER'S DISEASE ENROLLED IN THE PHASE IIA TRIAL OF ACTIVE IMMUNOTHERAPEUTIC VACCINE UB‐311
44. Dual-Isotope Cryoimaging Quantitative Autoradiography: Investigating Antibody–Drug Conjugate Distribution and Payload Delivery Through Imaging
45. Practical applications of machine learning in imaging trials
46. The Expansion of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva Is Activin A-Dependent
47. [P4-266]: APPLICATION OF A MULTI-ATLAS SEGMENTATION TOOL TO HIPPOCAMPUS, VENTRICLE AND WHOLE BRAIN SEGMENTATION
48. [IC-P-103]: APPLICATION OF A MULTI-ATLAS SEGMENTATION TOOL TO HIPPOCAMPUS, VENTRICLE, AND WHOLE BRAIN SEGMENTATION
49. Three-Dimensional Dosimetry for Radiation Safety Estimates from Intrathecal Administration
50. PHASE 2A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE HISTONE DEACETYLASE INHIBITOR (HDACI), FRM-0334, IN ASYMPTOMATIC CARRIERS OF, OR PATIENTS WITH FRONTOTEMPORAL LOBAR DEGENERATION (FTLD) DUE TO, PROGRANULIN GENE MUTATIONS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.